Three dividend-paying stocks stand out for investors seeking reliable income amid market challenges: Bristol Myers Squibb (BMY), Medtronic (MDT), and Gilead Sciences (GILD). Each company has faced headwinds, yet they have maintained and even increased their dividends, making them attractive options for income-focused portfolios.
Bristol Myers Squibb has navigated stiff competition and patent expirations while still delivering a 4.3% yield and a 28.6% increase in dividends over the past five years. Medtronic, with a 3.3% yield, has spun off its lower-margin diabetes unit and launched innovative products, contributing to its longest dividend growth streak of 48 years. Gilead Sciences, yielding 2.5%, is diversifying its portfolio beyond its COVID-19 treatment and is well-positioned to sustain its dividend with a low payout ratio.
Investors can consider these stocks as solid dividend plays that not only offer immediate income but also potential for future growth as they adapt to market dynamics.
Source: fool.com